Chapters
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
Argipressin injection | Hospital use only | ||
Corticorelin | Hospital use only | ||
Demeclocycline capsules | For the treatment of hyponatraemia resulting from inappropriate secretion of antidiuretic hormone. Unlicensed. | ||
Desmopressin injection | Hospital use only | ||
Desmopressin melts | Very high relative cost | ||
Desmopressin nasal solution | |||
Desmopressin nasal spray | |||
Desmopressin tablets | |||
Gonadorelin injection | Hospital use only | ||
Human chorionic gonadotrophins injection | |||
Human menopausal gonadotrophins injection (Menotrophin) | |||
Macimorelin | |||
Protirelin 200microgram/2ml injection | |||
Somatrogon (Ngenla®) | |||
Somatropin injection | |||
Terlipressin injection | Hospital use only | ||
Tetracosactide injection | |||
Tolvaptan (Jinarc®) | Tolvaptan (Jinarc) for treating autosomal dominant polycystic kidney disease | ||
Tolvaptan (Samsca®) | Consultant advice only. Tolvaptan (Samsca) for the treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.